One Case of Tremor Caused by Esketamine Injection

doi:10.19803/j.1672-8629.20250096

Abstract

Abstract: Objective To study the characteristics of esketamine-induced tremors and to provide references for safe medications. Methods One case of tremor caused by esketamine was studied. The adverse reactions and pathogenesis of tremors caused by esketamine were analyzed based on correlation evaluation and literature review. Recommendations about treatment and the priorities of pharmaceutical care were outlined. Results After the drug instructions and related literature were reviewed, the correlation between esketamine and tremors was determined as “possible”. The symptoms were gradually improved after discontinuation of esketamine. Conclusion Clinicians should be aware of the risk of tremors caused by esketamine and monitor for adverse reactions of esketamine to ensure the safety of patients.

Key words: Esketamine, Injection, Tremor, Adverse Drug Reactions, Pharmaceutical Care, Anesthetic

CLC Number:

R994.11

SU Su, WANG Moyi, MA Yiyi, LI Xiaoling, CHU Yanqi, ZHANG Lan. One Case of Tremor Caused by Esketamine Injection[J]. Chinese Journal of Pharmacovigilance, 2025, 22(10): 1174-1176.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20250096

https://zgywjj.magtechjournal.com/EN/Y2025/V22/I10/1174

References

[1] FEENEY A, PAPAKOSTAS GI.Pharmacotherapy: Ketamine and Esketamine[J]. The Psychiatric Clinics of North America, 2023, 46(2): 277-290.
[2] MION G, HIMMELSEHER S.Esketamine: Less Drowsiness, More Analgesia[J]. Anesthesia and Analgesia, 2024, 139(1): 78-91.
[3] BAIZABAL-CARVALLO JF, MORGAN JC. Drug-Induced Tremor, Clinical Features, Diagnostic Approach and Management[J]. Journal of the Neurological Sciences, 2022. 435: 120192.
[4] FENG Y, ZHANG M, JIA SY, et al.Dexamethasone Alleviates Etomidate-Induced Myoclonus by Reversing the Inhibition of Excitatory Amino Acid Transporters[J]. Frontiers in neuroscience, 2024, 18: 1399653.
[5] RAINESS RA, PATEL V, STANDER E.Etomidate Induced Seizure: Adverse Drug Event Case Report[J]. Journal of Pharmacy Practice[J]. 2022, 35(1): 126-128.
[6] DOENICKE AW, ROIZEN MF, KUGLER J, et al.Reducing Myoclonus after Etomidate[J]. Anesthesiology, 1999, 90(1): 113-119.
[7] IWASAKI F, MIMURA M, YAMAZAKI Y, et al.Generalized Tonic-Clonic Seizure Induced by Propofol in a Patient with Epilepsy[J]. Masui, 2001, 50(2): 168-170.
[8] GARG R, DEHRAN M.Convulsions with Propofol: a Rare Adverse Event[J]. Masui. Japanese Journal of Anesthesiology, 2009, 55(1): 69-71.
[9] RISSARDO JP, FORNARI CAPRARA AL, BHAL N, et al.Drug-Induced Myoclonus: a Systematic Review[J]. Medicina (Kaunas, Lithuania), 2025, 61(1): 131.
[10] YANG H, WEI J, WANG JY, et al.Study on Methods of Adverse Drug Reaction/Event Reporting Assessment[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2009, 6(10): 581-584.
[11] NARANJO CA, BUSTO U, SELLERS EM, et al.A Method for Estimating the Probability of Adverse Drug Reactions[J]. Clinical Pharmacology and Therapeutics, 1981, 30(2): 239-245.
[12] HASHIMOTO K, KAKIUCHI T, OHBA H, et al.Reduction of Dopamine D(2/3) Receptor Binding in the Striatum after a Single Administration of Esketamine, but not R-Ketamine: a PET Study in Conscious Monkeys[J]. European archives of Psychiatry and Clinical Neuroscience, 2017, 267(2): 173-176.
[13] RISSARDO JP, VORA N, MATHEW B, et al.Overview of Movement Disorders Secondary to Drugs[J]. Clinics and Practice, 2023, 13(4): 959-976.
[14] JELEN LA, YOUNG AH, STONE JM.Ketamine: a Tale of Two Enantiomers[J]. Journal of psychopharmacology (Oxford, England), 2021, 35(2): 109-123.
[15] FREI K, TRUONG DD.Medications Used to Treat Tremors[J]. Journal of the Neurological Sciences, 2022, 435: 120194.
[16] YAN M.Expert Consensus Guidelines on the Clinical Application of Esketamine[J]. International Journal of Anesthesiology and Resuscitation(国际麻醉学与复苏杂志), 2023, 44(8): 785-793.